🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05036850
Recruiting Observational

China Kidney Patient Trials Network

NCT05036850 · tracked via the Priya Life Science China tracker
Sponsor
George (Beijing) Clinical Research Co. Ltd.
Phase
Observational
Started
2021-09-27
Last updated
2023-03-06

Condition(s) studied

Kidney Diseases

Study summary

This is a prospective multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease in China.

Eligibility

Sex
ALL
Min age
2 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Documented diagnosis of primary kidney disease 2. Regular visits (at least 6 monthly) with a physician at a participating site 3. eGFR \> 15 ml/min/1.73 m2 4. ≥ 2 years of age 5. Willing and able to sign informed consent 6. Willing to be approached about participation in interventional research studies Exclusion Criteria: * 1\. Life-expectancy of less than 6 months

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
George Clinical (Beijing) Beijing Beijing Municipality Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05036850 on ClinicalTrials.gov ↗ ← All trials in China